Nano-in-micro alginate/chitosan hydrogel via electrospray technology for orally curcumin delivery to effectively alleviate ulcerative colitis

Chen Zhang,Xiao Wang,Meng Xiao,Jiaqi Ma,Yan Qu,Liang Zou,Jinming Zhang

DOI: https://doi.org/10.1016/j.matdes.2022.110894

2022-07-04

Abstract:Although nano-systems can promote the cellular internalization, polymeric nanoparticles (NPs) are easily to be destroyed or eliminated in the gastrointestinal tract, which leads to premature drug release or insufficient colonic accumulation. A novel oral nano-in-micro system for the efficient colonic delivery of curcumin (Cur) was developed in this study, in which the hyaluronic acid (HA)/zein complex NPs loading Cur were embedded in alginate/chitosan hydrogel microparticles () with the electrospray technology. The showed uniform-sized sphere with an average size of 218.36 ± 10 μm, encapsulating /zein NPs with the average size of 148.64 ± 3.21 nm. Cur in NMPs showed the sustained drug-release profiles in simulated gastric fluid, whereas it showed the rapid release in simulated colonic fluid. Mediated by the HA-CD44 receptor recognition, /zein NPs had the increased cellular uptake efficiency in macrophages. Furthermore, NMPs had the significant colon-retention and bio-adhesiveness capacity in colon tissues. As expected, the oral administration of significantly mitigated colitis symptoms in DSS-induced UC mice by inhibiting TLR4/NF-κB pathway. The above results can provide a useful drug delivery strategy for Cur in the treatment of UC by retaining the advantages of nano- and micro-scaled carriers.

materials science, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to construct a nano - in - micro system, and use electrospray technology to prepare sodium alginate/chitosan hydrogel microparticles (Cur@NMPs) for oral delivery of curcumin (Cur), so as to effectively relieve ulcerative colitis (UC). Specifically, the research aims to overcome the shortcomings of existing nano - drug delivery systems that are easily damaged or release drugs prematurely in the gastrointestinal tract, and design a new oral drug delivery system that can protect curcumin from damage in the upper gastrointestinal tract and specifically reach the colon lesion site.

The key issues in the paper include:
- **Drug stability**: How to improve the stability of curcumin in the gastrointestinal tract and avoid its premature release in the upper digestive tract.
- **Targeted delivery**: How to ensure that curcumin can effectively reach the colon lesion area, especially in inflammatory macrophages.
- **Therapeutic effect**: Verify whether this delivery system can significantly alleviate the symptoms of the DSS - induced mouse UC model and achieve anti - inflammatory effects by inhibiting the TLR4/NF - κB signaling pathway.

To achieve these goals, the researchers developed a new "nano - in - micro" system, in which curcumin is encapsulated in hyaluronic acid/zein nanoparticles (Cur@HA/zein NPs) and further wrapped in sodium alginate/chitosan hydrogel microparticles (Cur@NMPs). This design can not only protect curcumin from being damaged when passing through the gastrointestinal tract, but also increase the uptake efficiency of nanoparticles in inflammatory macrophages through the interaction between hyaluronic acid and CD44 receptors, thus playing an anti - inflammatory role more effectively.

The research results show that Cur@NMPs exhibit continuous drug - release characteristics in simulated gastric juice, while rapidly releasing in simulated colonic fluid, which helps the efficient accumulation of drugs at the colon lesion site. In addition, the experiment also confirmed that Cur@NMPs significantly alleviated colitis symptoms in the DSS - induced UC mouse model and played an anti - inflammatory role by inhibiting the TLR4/NF - κB signaling pathway. These findings provide a new strategy for the application of curcumin in UC treatment.